Feodor_Dostoievski-Idiotul-Partea_1-Capitolul_09.mp3

Q: How long is this episode of CartiAudio.eu?

Episode duration information is not available.

Q: When was this CartiAudio.eu episode published?

This episode was published on February 11, 2026.

Q: Can I download this CartiAudio.eu episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.

from CartiAudio.eu · host Feodor Dostoievski

Povestea printulului Lev Nikolaevici Miskin, considerat idiot de celelalte personaje din cauza sinceritatii si a bunatatii lui si numit astfel din cauza bolii de care suferea: epilepsie, fiind numita in popor idiotenie. Sfarsitului printului este unul tragic: in urma unei deceptii sentimentale cat si a uciderii celei care ar fi trebuit sa devina sotia sa de catre un prieten apropiat, printul

NOW PLAYING

Feodor_Dostoievski-Idiotul-Partea_1-Capitolul_09.mp3

0:00 0:00

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

Qual é a melhor cor?

May 14, 2026 ·2m

Porque é que os carros têm matrículas?

May 13, 2026 ·2m

Porque é que as meias desaparecem na máquina de lavar?

May 12, 2026 ·2m

Acordar cedo faz crescer?

May 11, 2026 ·1m

Os adultos brincam no trabalho?

May 8, 2026 ·4m

Neue Hoffnung für die Ukraine?

May 8, 2026 ·29m

Similar Podcasts

Agrifood Brief Euractiv Welcome to EURACTIV's AgriFood Brief, your weekly update on all things Agriculture & Food in the EU from EURACTIV's Agrifood news team: Gerardo Fortuna and Natasha Foote Evangelho✝️ ₿TC Jaraguá Evangelho✝️ ₿TC (Bitcoin) é a união de dois assuntos que trazem boas novas: Jesus é a salvação final e definitiva, e Bitcoin é uma proteção financeira na terra enquanto aguardamos o Seu retorno. ✝️ >₿Eu sou Jaraguá, e minha jornada foi singular: primeiro conheci o Bitcoin e, ao entender seu significado, encontrei Jesus.Este podcast tem um propósito educativo, onde estudamos a Palavra de Deus em busca da salvação eterna e refletimos sobre como o Bitcoin se alinha com esses princípios, oferecendo a liberdade financeira.Vamos juntos explorar essas conexões e aprofundar nosso entendimento? Destination: Europe (Forced Migration Review 51) Oxford University Europe is experiencing the mass movements of displaced people in a way that it has largely been immune from for decades. The manifestations of the 'migration crisis' are as disparate as the building of fences to stop people crossing normally peaceful borders, the deaths of people transported by smugglers in unseaworthy boats, EU political leaders bickering over a Common European Asylum System and the numbers they will or will not allow into their respective countries, and contentious responses to the disaster that continues to unfold in Syria. Alongside this we also see an upsurge of grass-roots compassion, solidarity and assistance to those whose human suffering on a grand scale in and around Europe constitutes the reality behind the rhetoric. FMR 51 includes 43 articles on 'Destination: Europe', plus five 'general' articles. Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere Julio G. Martinez-Clark Hosted by bioaccess® CEO, Julio G. Martinez-Clark, the Global Trial Accelerators™ podcast delivers actionable insights for Medtech, Biopharma, and Radiopharma innovators battling lengthy timelines and costly delays. Each episode features candid conversations with clinical trial pioneers, regulatory strategists, and startup founders who’ve slashed 6–12 months off approvals by leveraging emerging regions like Latin America, Eastern Europe, and Australia.What You’ll Learn:Speed Secrets: How to secure ethics approval in 4–6 weeks (vs. 6+ months in US/EU) using harmonized pathways like MINSA (Panama), ALIMS (Serbia), and Australia’s CTN.Cost-to-Speed Hacks: Operational strategies to reduce trial budgets by 30% while maintaining FDA/EMA compliance.Global Patient Access: Leverage treatment-naive populations in cardiology, rare diseases, and advanced therapies across 50+ pre-vetted sites.Why Listen?<ul

Frequently Asked Questions

How long is this episode of CartiAudio.eu?

Episode duration information is not available.

When was this CartiAudio.eu episode published?